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Hypoxia is an important developmental cue for multicellular organisms but it is also a contributing factor for several
human pathologies, such as stroke, cardiovascular diseases and cancer. In cells, hypoxia activates a major
transcriptional program coordinated by the Hypoxia Inducible Factor (HIF) family. HIF can activate more than one
hundred targets but not all of them are activated at the same time, and there is considerable cell type variability. In this
report we identified the paired-like homeodomain pituitary transcription factor (PITX1), as a transcription factor that
helps promote specificity in HIF-1a dependent target gene activation. Mechanistically, PITX1 associates with HIF-1b and
it is important for the induction of certain HIF-1 dependent genes but not all. In particular, PITX1 controls the HIF-1a-
dependent expression of the histone demethylases; JMJD2B, JMJD2A, JMJD2C and JMJD1B. Functionally, PITX1 is
required for the survival and proliferation responses in hypoxia, as PITX1 depleted cells have higher levels of apoptotic
markers and reduced proliferation. Overall, our study identified PITX1 as a key specificity factor in HIF-1a dependent
responses, suggesting PITX1 as a protein to target in hypoxic cancers.
Introduction
Hypoxia, or changes in the oxygen supply, initiates a potent
transcriptional program to allow cells to survive while attempting
to restore oxygen homeostasis. As such, a great number of tran-
scription factors are activated under hypoxic conditions 1, how-
ever, the hypoxia inducible factor (HIF) family, plays a crucial
and central role in this transcriptional response.
HIF is a heterodimer composed of an oxygen-regulated a sub-
unit and constitutively expressed b subunit. HIF-a subunits are
regulated by oxygen via the action of a class of dioxygenases
called prolyl-hydroxylases (PHD). PHDs require molecular oxy-
gen, iron and 2-oxoglutarate as cofactors for catalyzing the
hydroxylation of key proline residues in the oxygen-dependent
degradation domain of HIF-a.2 In addition to the regulation by
PHDs, HIF’s transcriptional activity is regulated by another type
of dioxygenase enzyme called Factor Inhibiting HIF (FIH). FIH
catalyzes the hydroxylation of an asparagine residue within the
transactivation domain of HIF-a:3 This modification prevents
binding of coactivators such as p300/CBP and thus inhibits
HIF-a full transcriptional activation.4,5
HIF activation leads to the upregulation of a variety of genes
involved in angiogenesis, proliferation and autophagy. However,
not all genes are activated in the same cell at the same time, sug-
gesting the presence of specificity determinants such as co-activa-
tors and co-repressors, or specific binding partners that direct
HIF to particular promoters.5,6
Hypoxia is an important component of many human diseases
such as stroke and cancer. In particular HIF expression has been used
as a prognostic marker in cancers such as colorectal and breast.7,8
Given the importance of this pathway in the pathology and response
to treatment of cancer, identification of specificity determinants of
the HIF response could lead to novel therapeutic approaches.
One protein that is often repressed in cancers such as colorectal
and lung is the paired-like homeodomain pituitary transcription fac-
tor PITX1.9,10 PITX1 is required for pituitary gland and hind limb
development.11 It is also known to interact functionally with other
transcription factors such as SF-1 and basic helix-loop-helix tran-
scription factors.12 More recently, PITX1 was identified in a screen
for suppressors of RAS activity and tumor promotion,13 and also
shown to repress TERT expression inmelanoma cell lines.14
Here we show that PITX1 is a novel specificity determinant for
HIF-1a activity. Depletion of PITX1 leads to differential expression
of a subset of HIF-1a target genes and results in increased apoptosis
in response to hypoxia. While most HIF-1a targets were unaffected
by PITX1, a number of JMJC protein demethylases were specifically
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altered. PITX1 was found to be important for the induction of
JMJD2B, a histone demethylase with particular importance for
breast and colorectal cancer progression. Furthermore, PITX1
reduction leads to changes in the proliferative ability of cells. Mecha-
nistically, PITX1 regulates HIF-1a activity by binding to HIF-1b
and regulating HIF recruitment to specific target promoters.
Results
PITX1 depletion results in higher HIF activity under
hypoxic stress
To investigate if PITX1 plays a role in the molecular response
to hypoxia, cells were depleted of PITX1 by siRNA and exposed
to hypoxia for 24 hours. HIF transcriptional activity was assessed
using luciferase reporter assays (Fig. 1A). In HRE-luciferase
reporter cells, PITX1 depletion resulted in increased HIF tran-
scriptional activity in U2OS and HeLa cells (Fig. 1A, Sup.
Fig. S1A). To rule out off target effects of siRNA, we analyzed an
additional siRNA oligonucleotide sequence targeting PITX1
(Fig. 1B). Cells were exposed to 1% O2 for 24 hours prior to
analysis of the luciferase assay. Under these conditions, PITX1
depletion using a different siRNA, also resulted in increased HIF
transcriptional activity, indicating that the increased HIF tran-
scriptional activity we detected with PITX1 depletion are not
due to off target effects. Furthermore, PITX1 mediated effects on
HIF dependent reporter activity were completely ablated when
PITX1 was co-depleted with HIF-1a (Sup. Fig. S1C) demon-
strating the specificity of the reporters and that PITX1 depletion
is altering HIF-1a activity specifically.
As PITX1 is a transcription factor, it was possible that PITX1
depletion was causing a general transcriptional activation. To test
this hypothesis, activity of a different transcription factor, NF-
kB, was assessed following a known activating stimulus, TNF-a
(Fig. S1D). Under these conditions, PITX1 depletion did not
result in any significant increase in NF-kB activity, suggesting a
degree of specificity for the effects observed.
We next determined if increased levels of PITX1 would have
the opposite effect. U2OS cells were chosen due to lower endoge-
nous levels of PITX1. Increasing amounts of PITX1 were trans-
fected into U2OS-HRE luciferase cells prior to exposure to 1%
O2 for 24 hours. While lower levels of overexpression resulted in
reduced HIF activity, higher levels of PITX1 expression resulted
in a slight increase of HIF activity (Fig. 1C, Sup Fig. S1E). These
results indicate that PITX1 has a threshold level that can interfere
with HIF activity, suggestive of a role as a transcriptional mod-
ulator. It also rules out off target effects of the use of siRNA.
PITX1 modulates HIF activity via a post-transcriptional
mechanism
As HIF activity is closely related to its expression levels, we
next determined if changes in PITX1 resulted in changes in HIF-
1a mRNA. PITX1 depletion did not result in any significant
change to HIF-1a mRNA in both U2OS and HeLa cells
(Fig. 1D, Sup. Fig. 1F), indicating that PITX1 modulating of
HIF activity is post-transcriptional.
PITX1 depletion results in differential regulation of HIF-1a
targets under hypoxic stress
Our analysis revealed an increase in HIF-1a transcriptional
activity, when PITX1 was depleted assessed by reporter gene
assay, with no change observed at the mRNA levels of HIF-1a.
To investigate if PITX1 depletion alters HIFs protein levels, we
exposed cells to different times of hypoxia and analyzed HIF pro-
teins by western blot (Fig. 2A). In the absence of PITX1, we did
not detect any significant changes to the levels of HIF-1a, HIF-
2a or HIF-1b proteins in both of the cell lines tested.
U2OS cells have much lower protein levels of PITX1 when
compared to HeLa cells (Sup. Fig. 2A), we used both cells to
investigate the levels of HIF targets in the absence of PITX1 in
response to hypoxia (Sup. Fig. S2B, C). Interestingly, while hyp-
oxia can reduce the levels of PITX1 mRNA in U2OS cells, it has
minimal effects in HeLa cells (Sup. Fig. 2B). In response to hyp-
oxia, we did not observe any significant changes in a variety of
HIF-dependent targets including PHD3, CA9 and GLUT1
(Fig. S2C).
One interesting class of HIF targets is the jumonji C Domain
(JmJC) enzymes.5 Most of these are histone demethylases and
hence by changing histone methylation patterns, and chromatin
structure, can induce changes in gene expression quite rapidly.15
Depletion of PITX1 resulted in reduced levels of JMJD2B, and
increased levels of JMJD1B, JMJD2A and JMJD2C (Fig. 2B,
Sup. Fig. S2C, D). Interestingly, we also could detect a visible
increase in the levels of histone H3 Lysine 9 trimethylation
(H3K9me3), following PITX1 depletion (Fig. 2B), a mark that
is targeted by a variety of these JmJC proteins, including
JMJD2B.16,17 Similar results were also obtained with an inde-
pendent siRNA oligonucleotide targeting PITX1 (Fig. 2C).
Importantly, increased levels of PITX1 achieved following over-
expression of an exogenous plasmid, resulted in higher levels of
JMJD2B and reduced levels of JMJD2C (Fig. 2D), while no
change was observed for JMJD2A. These results support the
notion of a dynamic regulation of JMJD2B and JMJD2C by
PITX1.
As JMJD2B and PITX1 are deregulated in breast cancer,18–20
we also analyzed the effect of PITX1 depletion in breast cancer
cell lines. Using the same reporter system as in Fig. 1, we ana-
lyzed MDA-MB-231 HRE-luciferase reporter activity in the
absence and presence of PITX1 (Fig. 2E). As observed with
U2OS and HeLa cells, PITX1 depletion resulted in enhanced
HIF-reporter activity in MDA-MB-231 breast cancer cells. To
determine if, in the context of breast cancer, PITX1 also controls
JMJD2B expression, we also analyzed the effects of PITX1 deple-
tion on JMJD2B protein levels in MDA-MB-231 and MCF-7
cells. In both these cell lines, PITX1 is required for JMJD2B
expression following hypoxia (Fig. 2F and Sup. Fig. S2E).
PITX1 and HIF-1a cooperate to control JMJC expression
in cells
JMJD2B has been associated with the HIF response in a num-
ber of tissues.20,21 Furthermore, JMJD2B levels are de-regulated
in a number of human cancers, suggesting that this is an impor-
tant protein.22 Given our findings that PITX1 impacts on HIF-
www.landesbioscience.com 3879Cell Cycle
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Figure 1. PITX1 levels control HIF transcriptional activity under hypoxic stress. (A) U2OS and HeLa cells stably expressing an HRE-luciferase reporter plas-
mid were transfected with control and PITX1 siRNA oligonucleotides prior to treatment with 1% O2 for 24 hours. Luciferase activity was measured
48 hours post-transfection. Graph depicts mean and standard deviation of a minimum of 3 independent experiments. Student’s t-test was performed to
calculate p values, and levels of significance are denoted as follows: *P < 0.05, **P < 0.01, and ***P < 0.001. (B) U2OS and HeLa-HRE luciferase cells were
transfected with control and PITX1_B siRNA oligonucleotides prior to treatment with 1% O2 for 24 hours. Luciferase activity was measured 48 hours
post-transfection. Graph depicts mean and standard deviation of a minimum of 3 independent experiments. Student’s t-test was performed to calculate
p values, and levels of significance are denoted as follows: *P < 0.05, **P < 0.01, and ***P < 0.001. (C) U2OS-HRE luciferase cells were transfected with
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1a transcriptional activity, we next determined the mechanism
by PITX1 depletion altered expression of JmJC proteins. When
PITX1 was depleted in U2OS and HeLa cells, we found that
JMJD2B mRNA levels were significantly reduced both in nor-
moxia and hypoxia (Fig. 3A, Sup. Fig. 3A, B). This analysis indi-
cated that PITX1 is required for the expression of JMJD2B in
both the cell lines analyzed. However, levels of JMJD2A and
JMJD2C mRNA were increased when PITX1 was depleted in
hypoxia, suggesting that PITX1 acts as a repressor of these genes
(Fig. 3A, Sup. Fig. 3A, B).
Since some of the JmJC proteins are HIF-1a targets, we next
determined if the JmJC proteins we have analyzed were con-
trolled by HIF-1a in hypoxia (Fig. 3B). While JMJD2B and
JMJD2C protein levels were reduced following HIF-1a deple-
tion, JMJD1B and JMJD2A proteins were increased in the
absence of HIF-1a (Fig. 3B). Given this dual function of HIF-
1a and PITX1, we investigated if PITX1 effects on JmJC protein
expression was dependent or not on HIF-1a. To this end, we
performed co-depletion experiments where PITX1 and HIF-1a
were simultaneously reduced by siRNA (Fig. 3C). This analysis
revealed that HIF-1a depletion is dominant over PITX1 reduc-
tion. In other words, HIF-1a co-depletion with PITX1 reversed
the increased levels of JMJD2C, and did not further reduce
JMJD2B protein expression. Similar results where also observed
for JMJD1B and JMJD2A, 2 proteins that are increased in the
absence of HIF-1a or PITX1. In PITX1 and HIF-1a co-deple-
tion conditions, levels JMJD1B and JMJD2A proteins do not
further increase, suggesting that PITX1 and HIF-1a operate in
the same regulatory pathway. Interestingly, this is also the case
for the levels of H3K9me3.
H3K9me3 can be removed by several histone demethylases,
such as JMJD2A, JMJD2B, JMJD2C.23 Since we observed an
increase in JMJD2A and JMJD2C but a decrease in JMJD2B,
we wanted to understand how these enzymes interplay with each
other to regulate this histone mark. To do this, we conducted
siRNA mediated depletion of several these enzymes and analyzed
the levels of H3K9me3. Our analysis revealed that JMJD1B is
the most potent histone demethylase for H3K9me3 in HeLa
cells, but that JMJD2B and JMJD2C also participate in this pro-
cess (Fig. 3D and Sup Fig. S3C).
PITX1 modulates HIF-1a activity by interaction with
HIF-1b
Thus far, we have established that PITX1 is a modulator of
HIF-1a transcriptional activity. However, our results suggest
that this effect is not mediated via the control of HIF-1a
mRNA. We thus investigated if PITX1 was able to form a com-
plex with HIF. To determine if this is the case, we performed co-
immunoprecipitations for PITX1 and analyzed if HIF subunits
were present in a complex in normoxia and hypoxia. Although,
we were unable to detect HIF-1a interaction with PITX1, HIF-
1b was readily detectable in PITX1 immunocomplexes, under
normoxic and hypoxic conditions (Fig. 4A). PITX1 interaction
with HIF-1b was also observed in co-transfection experiments,
using tagged proteins, further supporting the notion that these 2
proteins interact (Fig. 4B). We could also confirm these bio-
chemical results using immunofluorescence analysis (Fig. 4C),
where quantification of colocalisation between HIF-1b and
PITX1 using Fiji software revealed a Spearman’s rank correlation
coefficient of 0.84 in normoxia or 0.82 in hypoxia. Finally, to
demonstrate that indeed PITX1 interacts with HIF-1b in cells,
we employed a FRET approach using mCherry-PITX1 and
GFP-HIF-1b transfected cells (Fig. 4D, Sup. Fig. S4C). If 2
tagged-proteins interact, then, there is energy transfer from the
donor fluorophore (GFP) to the acceptor fluorophore
(mCherry). Based on this principal, if the acceptor is photo-
bleached, one would expect an increase in the donour fluores-
cence intensity.24 When, mCherry and GFP vectors were co-
transfected into cells, acceptor photobleaching did not result in
any measurable increase in GFP intensity as expected (Sup.
Fig. S4C), indicating that mCherry and GFP do not normally
interact in cells. However, when analyzing mCherry-PITX1 and
GFP-HIF-1b co-transfected cells, after mCherry-PITX1 photo-
bleaching, a visible increase in GFP-HIF-1b intensity was readily
observed (Fig. 4D). FRET efficiency based on the level of
increased GFP intensity, was measured at 49.9% (with standard
deviation of 21.2), indicating that indeed PITX1 interaction
with HIF-1b is as robust as seen biochemically (Fig. 4A, B).
Taken together these analyses demonstrate the strong interaction
observed between PITX1 and HIF-1b.
One possible explanation for the modulation of HIF activity,
would be the possible disruption of HIF-1a/HIF-1b hetero-
dimer in the absence/presence of PITX1. To test this hypothesis,
we analyzed the levels of HIF-1a/HIF-1b complex formation in
the presence or absence of PITX1. Under conditions of PITX1
depletion, HIF-1a was able to readily complex with HIF-1b
(Fig. 4E). Again, we could confirm this observation using immu-
nofluorescence for HIF-1a and HIF-1b, in the presence or
absence of PITX1 (Fig. 4F). When we used Fiji to quantify the
colocalisation between HIF-1a and HIF-1b, in presence or
absence of PITX1, we could only detect a small reduction in the
colocalisation statistics. Spearman’s rank correlation coefficient
for HIF-1a and HIF-1b colocalisation in control cells was 0.82,
while in the absence of PITX1 this was 0.75. This suggests that
PITX1 does not change HIF heterodimer complex in a signifi-
cant manner.
Given, that we did not observe changes in all HIF-dependent
genes, we hypothesized that PITX1 action was being sensed at
specific HIF-dependent target gene promoters. To test this, we
focused on the JMJD2B promoter. We performed Chromatin
Figure 1 (See previous page). empty vector or increasing concentration of PITX1 expression construct (0.1, 0.25, 0.5 1 and 2 mg) prior to exposure to 1%
O2 for 24 hours. Luciferase activity was measured 48 hours post-transfection. For all graphs, data was normalized to control hypoxia treated sample. (D)
U2OS and HeLs cells were transfected with control or PITX1 siRNA oligonucleotides for 48 hours prior to total RNA extraction. Levels of HIF-1a mRNA
were analyzed by qPCR. Graph depicts mean and standard deviation of a minimum of 3 independent experiments. Data was normalized using actin and
compared to control siRNA.
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Figure 2. PITX1 is a specificity determinant for HIF-1a-dependent target gene activation. (A) U2OS and HeLa cells were transfected with control or PITX1
siRNA, prior to treatment with 1% O2 for 24 hours. Whole cell lysates were obtained 48 hours post-transfection and analyzed by protein gel blot using
the indicated antibodies. (B) HeLa cells were transfected with control or PITX1 siRNA, prior to treatment with 1% O2 for the indicated periods of time.
Whole cell lysates were obtained 48 hours post-transfection and analyzed by western blot using the indicated antibodies. (C) HeLa cells were trans-
fected, processed and analyzed as in B. (D) U2OS were co-transfected with 1 mg of GFP-HIF-1b and increasing amounts of PITX1 plasmid (0.1, 0.25 and
0.5 mg) prior to exposure to 1% O2 for 24 hours. Whole cell lysates were obtained 48 hours post-transfection and analyzed by protein gel blot using the
indicated antibodies. (E) MDA-MB-231-HRE cells were transfected with control and PITX1 siRNA oligonucleotides prior to treatment with 1% O2 for
24 hours. Luciferase activity was measured 48 hours post-transfection. Graph depicts mean and standard deviation of a minimum of 3 independent
experiments. Student’s t-test was performed to calculate p values, and levels of significance are denoted as follows: *P < 0.05, **P < 0.01, and ***P <
0.001. (F) MDA-MB-231 cells were transfected with control and PITX1 siRNA oligonucleotides prior to treatment to 1% O2 for 24 hours. Whole cell lysates
were obtained 48 hours post-transfection and analyzed by western blot using the indicated antibodies.
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Figure 3. PITX1 regulates JMJD2B and JMJD2C expression in a HIF-1a-dependent manner. (A) HeLa cells were transfected with control or PITX1 siRNA,
prior to treatment with 1% O2 for 24 hours. Total mRNA was extracted and levels of JMJD2A, JMJD2B and JMJD2C mRNA were analyzed by qPCR. Graph
depicts mean and standard deviation of a minimum of 3 independent experiments. Data was normalized using actin and compared to control siRNA.
Student’s t-test was performed to calculate p values, and levels of significance are denoted as follows: *P < 0.05, **P < 0.01, and ***P < 0.001. (B) HeLa
cells were transfected with control or HIF-1a siRNA, prior to treatment with 1% O2 for 24 hours. Whole cell lysates were obtained 48 hours post-transfec-
tion and analyzed by protein gel blot using the indicated antibodies. (C) HeLa cells were transfected with control, PITX1, HIF-1a or PITX1 and HIF-1a
siRNA, prior to treatment with 1% O2 for 24 hours. Whole cell lysates were obtained 48 hours post-transfection and analyzed by western blot using the
indicated antibodies. (D) HeLa cells were transfected with the indicated siRNAs oligonucleotides prior to treatment with 1% O2 for 24 hours. Whole cell
lysates were obtained 48 hours post-transfection and analyzed by protein gel blot using the indicated antibodies.
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Figure 4. PITX1 binds HIF-1b but not HIF-1a and it does not disrupt the HIF-1a/HIF-1b heterodimer in a general manner. (A) HeLa cells were treated or
not with 1% O2 for 24 hours prior to whole cell lysis. 300 mg of protein were used to immunoprecipitate PITX1, using specific antibodies. Rabbit IgG was
used as a negative control. Immunocomplexes were analyzed by western blot using the indicated antibodies. (B) Hek293 cells were transfected with
4 mg of empty vectors or GFP-HIF-1b and mCherry-PITX1 (mCh-PITX1) expression constructs for 48 hours prior to lysis. 300 mg of whole cell lysates were
used to immunoprecipitate HIF-1b and normal rabbit IgG was used as a control. Immunocomplexes were analyzed by protein gel blot using the
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Immunoprecipitation (ChIP) analysis for HIF-1a and HIF-1b,
in the presence and absence of PITX1. ChIP revealed that in the
absence of PITX1, there are significantly less HIF-1b and HIF-
1a present at the JMJD2B promoter (Fig. 5A). This suggests
that PITX1 is necessary to maintain the HIF heterodimer at the
JMJD2B promoter. Interestingly, we could observe increased lev-
els of HIF-1b present at the JMJD2C and JMJD2A promoters
but no significant change in the CA9 promoter (Fig. 5B). Fur-
thermore, levels of HIF-1a were not significantly altered in the
JMJC2C and JMJC2A promoters (Fig. 5B). Finally, we investi-
gated if increased PITX1 levels could alter HIF-1b presence at
the JMJD2 promoters analyzed. Given the difficulties of achiev-
ing similar levels of expression, we could only obtain statistically
significant results for the JMJD2A promoter, where PITX1 over-
expression results in reduced levels of HIF-1b in normoxia
(Fig. 5C). However, we could detect a tendency for increased lev-
els of HIF-1b at the JMJD2B promoter and a reduction in the
JMJD2C promoter (Fig. 5C). These results are the opposite of
those observed when PITX1 is depleted (Fig. 5A, B). Taken
together, these results confirm that PITX1 confers gene selectivity
in the HIF-1 transcriptional response via modulation of HIF-1b
presence at particular promoters.
PITX1 depletion results in changes of the cellular responses
to hypoxia
Hypoxia can induce a variety of cellular responses depend-
ing on cell context.25 To investigate the role of PITX1 in the
cellular response to hypoxia, we started by analyzing markers
of cell death/survival such as apoptosis and autophagy. In both
U2OS and HeLa cells, when PITX1 was depleted and cells
exposed to hypoxia, we observed increased levels of cleaved
PARP, indicative of increased apoptosis. On the other hand,
levels of p62, a protein essential for autophagy, and usually
used as a marker of this process, were high in HeLa cells when
PITX1 was depleted, but these still were reduced with hypoxia
exposure (Fig. 6A). In agreement with this similar reduction,
LC3 cleavage, another marker of autophagy was unchanged by
the presence or absence of PITX1 (Fig. 6A). These results
were also observed when cells were analyzed for the level of
Annexin V staining using flow cytometry (Fig. 6B) and analy-
sis of sub-G1 levels in cells cell cycle profile also detected by
flow cytometry (Fig. 6C). Both these types of measurements
indicate that PITX1 depletion results in increased levels of
apoptotic cell death in HeLa cells.
Hypoxia has also been reported to induce changes in the pro-
liferation and migration capacity of cancer cells.7 In HeLa cells,
we could detect a small but significant increase in cell
proliferation following exposure to 24 hours of hypoxia (Sup.
Fig. 5A). To address if PITX1 is involved in any of these
responses, we analyzed the effects of depletion and overexpression
of PITX1 in HeLa cells exposed to hypoxia in terms of their pro-
liferation (Fig. 6D). While depletion of PITX1 results in a signif-
icant reduction in proliferation, overexpression of PITX1
resulted in higher proliferation levels in hypoxia (Fig. 6D).
To further determine the effect of PITX1 on cell proliferation,
we analyzed the cell cycle profile of HeLa cells in the presence or
absence of PITX1, treated or not with hypoxia for 24 hours
(Fig. 6E; Sup. Fig. S5B). Apart from significant changes observed
in sub-G1 cell numbers (Fig. 6C), we could also detect a significant
reduction in the number of cells present in S-phase both in nor-
moxia and hypoxia, when PITX1 is depleted (Fig. 6E). However,
no additional significant changes could be observed in G1 or G2/
M phases of the cell cycle, regardless of treatment (Sup. Fig. S5B).
The effect on cell proliferation/viability by PITX1 was also
confirmed when colony formation potential was assessed
(Fig. 6F). While, depletion of PITX1 resulted in a reduction in
the number of colonies formed in hypoxia, overexpression pro-
duced the opposite effect (Fig. 6F, Sup Fig. S5C). These results
suggest that PITX1 is required for the proliferative capacity of
cells, even in hypoxia.
Discussion
In this report we have investigated the role of PITX1 in the
cellular response to hypoxia. We have found that PITX1 is a tar-
get-specific HIF-1a modulator, resulting in differential expres-
sion of certain HIF-1a targets following hypoxia. In particular,
we have found that PITX1 is required for JMJD2B expression,
an important histone demethylase often found deregulated in
cancer and HIF-dependent target. Mechanistically, we found
that PITX1 associates with HIF1b and this is required for hetero-
dimer loading at specific HIF promoters. Finally, we demon-
strated that PITX1 is required for cell survival and proliferation
of cells in hypoxia, suggesting that PITX1 could be a promising
target for cancer therapy.
PITX1 was originally identified as a gene involved in pituitary
gland gene expression,11 as well as being important for mesoderm
specification. In the mouse, deletion of PITX1 results in hin-
dlimb impairment.26 It has also been shown that PITX1 can
have cell and gene-specific activities via its physical interaction
with additional transcription factors.27-29 One of these studies
identified NeuroD1/Pan1 as an interacting partner for PITX1.12
NeuroD1 is part of the basic helix-loop-helix transcription
Figure 4 (See previous page). indicated antibodies. (C) HeLa cells were treated or not with 1% O2 for 24 hours prior to being fixed and stained for
immunofluorescence using the indicated antibodies. Images were acquired using a DeltaVision microscope, deconvolved and processed using OMERO
client (opensource software). (D) Hela cells were co-transfected with 1 mg of mCherry-PITX1 (mCh-PITX1) and 1 mg of GFP-HIF-1b, as indicated, for
48 hours prior to fixation. Images were acquired before and after acceptor photo-bleaching as indicated in the methods. (E) HeLa cells were transfected
with control or PITX1 siRNA, prior to treatment with 1% O2 for 24 hours. Whole cell lysates were obtained and 300 mg of protein were used to immu-
noprecipitate HIF-1a, using specific antibodies. Mouse IgG was used as a negative control. Immunocomplexes were analyzed by western blot using the
indicated antibodies. (F) HeLa cells were transfected with control or PITX1 siRNA, prior to treatment with 1% O2 for 24 hours prior to being fixed and
stained for immunofluorescence using the indicated antibodies. Images were acquired using a DeltaVision microscope, deconvolved and processed
using OMERO client.
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Figure 5. PITX1 controls HIF-1b levels at the JMJD2A, JMJD2B and JMJD2C promoters. (A) HeLa cells were transfected with control or PITX1 siRNA, prior
to treatment with 1% O2 for 24 hours. Cells crosslinked and processed for chromatin immunoprecipitation, using HIF-1a and HIF-1b antibodies. Levels
of these transcription factors were analyzed at the JMJD2B promoter by qPCR. Graph depicts mean and standard deviation of a minimum of 3 indepen-
dent experiments. Student’s t-test was performed to calculate p values, and levels of significance are denoted as follows: *P < 0.05, **P < 0.01, and
***P < 0.001. (B) HeLa cells were treated and processed as in A, but levels of HIF-1b present at the JMJD2A, JMJD2C and CA9 promoters were analyzed.
Levels of HIF-1a are also presented for JMJD2A and JMJD2C. Graph depicts mean and standard deviation of a minimum of 3 independent experiments,
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factors group, which are transcription factors important for tissue
identity.12 Interestingly, HIFs are also bHLH transcription fac-
tors, but possess one additional domain, Per-Arnt-SIM (PAS).30
Our results indicate that PITX1 binds to HIF-1b, but we could
not detect HIF-1a consistently. While it is possible that this is
due to antibody efficiency, our analysis is more consistent with
the hypothesis that PITX1 preferentially binds HIF-1b, since
this interaction is observed in normoxia, a condition where HIF-
1a is not available. Additional studies, analyzing if this interac-
tion is also observed in vitro, as well as domain mapping, would
identify which domains are required for this complex formation.
PITX1 was found to be required to suppress RAS induced
tumourigenesis; furthermore, several studies have shown that
PITX1 expression is reduced in colorectal, prostate and lung can-
cer.13 However, PITX1 function has not been investigated in cer-
vical or osteosarcoma types of cancer cells. Our analysis here, adds
additional information regarding PITX1 function in these differ-
ent cellular backgrounds. Interestingly, PITX1 is found overex-
pressed in breast cancer.10,31 PITX1 is responsive to estrogen, and
is required for gene expression mediated by Estrogen receptor-
a.32 HIF role in cancer has been extensively documented.7,33
However, different HIF-a isoforms have different functional out-
comes for the cell.34 HIF-1a has been mostly studied and depend-
ing on the cancer/cell type it can be a tumor promoter or tumor
suppressor.34 Another interesting aspect is the temporal expression
of the isoforms, with HIF-1a being the first HIF to be induced
and HIF-2a being expressed after prolonged hypoxia exposure.34
We have only analyzed the acute response to hypoxia, in
the presence or absence of PITX1. As such, our results are
related to HIF-1a dependent gene expression. PITX1 reduc-
tion results in an increased HIF transcriptional activity, using
a generic reporter assay. However, more detailed analysis
revealed that only some targets are de-repressed in the absence
of PITX1, while others actually require PITX1 for full hypoxia
induction. It is also very likely that PITX1 can also regulate
HIF-2 dependent genes due to its binding to HIF-1b. Addi-
tional studies, investigating HIF-2 mediated responses will
answer this question.
One interesting class of HIF-dependent genes that are altered
by modulation of PITX1 is the JMJC demethylase enzymes. In
particular, JMJD2B (JMJD2B) expression was particularly sensi-
tive to PITX1 depletion. JMJD2B is a histone demethylase with
preference for Lysine 9 when tri-methylated on Histone 3.35 Fur-
thermore, JMJD2B overexpression has been found in breast can-
cer and it is required for hormonal responsive cancer in this
tissue.20 Like PITX1,32 JMJD2B is also regulated by estrogen.19
Interestingly, we could also observe that PITX1 mediated regula-
tion of JMJD2B in breast cancer cell lines such as MDA-MB-
213 and MCF-7. More recently, JMJD2B has also been shown
to participate in colorectal cancer, via a HIF dependent mecha-
nism.21 Given our result with PITX1, it is possible that targeting
PITX1 or JMJD2B in hypoxia would be a valid novel therapeutic
approach for hypoxic tumors.
We found that PITX1 has a differential effect on JMJC pro-
tein expression. While JMJD2B requires PITX1 and HIF-1a,
JMJD1B expression is regulated independently of HIF-1a. On
the other hand, JMJD2A and JMJD2C both require HIF-1a for
their expression and PITX1 effects on these proteins are also HIF
dependent. We also determined, which of these enzymes has the
most potent effect on H3K9me3 levels in HeLa cells. Our results
identified JMJD1B as the most effective histone demethylase for
this site in HeLa cells. Interestingly, JMJD2B and JMJD2C also
have a contribution toward the regulation of this histone mark in
these cells. It would be interesting to further investigate these
effects on particular genes, as these enzymes might be specifically
targeted to particular genomic loci. However, since these enzymes
are relatively understudied, novel additional work will be neces-
sary for the understanding of their biological functions in cells.
Materials and Methods
Cells
Human embryonic kidney Hek293, U2OS osteosarcoma,
HeLa cervical cancer and MDA-MB-231 cell lines were obtained
from the European Collection of Cell Cultures and grown in
Dulbecco’s Modified Eagle Medium (Lonza) supplemented with
10% fetal bovine serum (Gibco), 50 units/ml penicillin (Lonza),
and 50 mg/ml streptomycin (Lonza) for no more than 30 pas-
sages at 37C and 5%CO2. Stable cell lines U2OS-HRE-lucifer-
ase, Hela-HRE-luciferase were described in 36 and maintained in
0.5mg/mL puromycin. MDA-MB-231-HRE cells were created
as U2OS and HeLa-HRE cells, and also maintained in 0.5mg/
mL puromycin.
Plasmids
CMV-PITX1 was obtained from Origene. GFP-ARNT
(HIF-1b) was a kind gift from Prof. Colin Duckett (Michigan,
USA). mCherry-PITX1 was created by cloning PITX1 into
mCherry-C1 (clontech). Vectors were sequenced to verify iden-
tity using our in house sequencing facility.
siRNA transfection
siRNA duplex oligonucleotides were synthesized by MWG-
Eurofins and transfected using Interferin (Polyplus) per the man-
ufacturer’s instructions.
siRNA sequences are as follows:
Control, AAC AGU CGC GUU UGC GAC UGG 37;
Figure 5 (See previous page). except for JMJD2A, which presents the mean and standard deviation of 2 independent experiments. Student’s t-test was
performed to calculate p values, and levels of significance are denoted as follows: *P < 0.05, **P < 0.01, and ***P < 0.001. (C) HeLa cells were co-trans-
fected with HIF-1b and empty vector or PITX1 expression constructs for 48 hours prior to crosslinked and lysed. Chromatin immunoprecipitation was
performed using the indicated antibodies. Levels of HIF-1b were analyzed at the indicated promoters by qPCR. Graph depicts mean and standard devia-
tion of a minimum of 3 independent experiments. Student’s t-test was performed to calculate p values, and levels of significance are denoted as follows:
*P < 0.05, **P < 0.01, and ***P < 0.001.
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Figure 6. PITX1 regulates cell viability and proliferation in hypoxia. (A) U2OS and HeLa cells were transfected with control or PITX1 siRNA, prior to treat-
ment with 1% O2 for the indicated periods of time. Whole cell lysates were obtained 48 hours post-transfection and analyzed by protein gel blot using
the indicated antibodies. (B) HeLa cells were transfected with control and PITX1 siRNA oligonucleotides prior to treatment with 1% O2 for 24 hours.
48 hours after transfection, cells were trypsinized and analyzed for Apoptosis by flow cytometry. Graph depicts mean and standard deviation from a min-
imum of 3 independent experiments (C) HeLa cells were treated as in B, but cells were fixed prior to cell cycle analysis. Graph depicts mean a standard
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HIF-1, CUG AUG ACC AGC AAC UUG A37;
PITX1, GCU UCA CCU UCU UCA ACU C
PITX1_B, GAG CUU CAC CUU CUU CAA C
JMJD2A, GAG UUA UCA ACU CAA GAU A
JMJD2B, CGG CCA CAU UAC CCU CCA A
JMJD2C, GGC GCC AAG UGA UGA AGA A
JMJD1A, CUU AGU UGG UUC AGA AGU A
Hypoxia inductions
Cells were incubated at 1% O2 in an in vivo 300 hypoxia
workstation (Ruskin, UK), or in a H35 Don Whitley Scientific
workstation. Cells were lysed for protein extracts, and RNA
extraction in the workstation to avoid re-oxygenation. Whole cell
lysates were obtained using a NP-40 lysis buffer (50 mM Tris
pH8, 150 mM NaCl, 1% NP-40 (Calbiochem), 2 mM EDTA,
250 M Na3VO4, 1 mM DTT, 10 mM NaF and phosphatase
inhibitors 1 tablet/10 mL (Roche complete)) RNA was extracted
using PeqGOLD Total RNA Kit (Peqlab) as per manufacturer’s
instructions.
qPCR and PCR sequences
cDNA was made using QuantiTect Rev. Transcription Kit
(Qiagen) and analyzed using Stratagene Mx3005p PCR machine
and Brilliant II SYBR Green QPCR Low ROX Master Mix
(600830, Agilent).
PCR primers are as follows:
HIF-1a: For, CAT AAA GTC TGC AAC ATG GAA GGT
and Rev, ATT TGA TGG GTG AGG AAT GGG TT;
b-actin: For, GTG GGA GTG GGT GGA GGC and Rev,
TCA ACT GGT CTC AAG TCA GTG;
JMJD2A: For, TGT GCT GTG CTC CTG TAG and Rev,
GTC TCC TTC CTC TCC ATC C;
JMJD2B: For, GGG GAG GAA GAT GTG AGT GA and
Rev, GAC GGC TTT TGG AGG GTA AT;
JMJD2C: For, CGA GGT GGA AAG TCC TCT GAA and
Rev, GGG CTC CTT TAG ACT CCA TGT AT.
Chromatin immunoprecipitation (ChIP)
Proteins were cross-linked with formaldehyde for 10 min.
0.125 mol/L glycine was added, and cells washed with phos-
phate-buffered saline. Cells were lysed with lysis buffer (1%
SDS, 10 mM EDTA,50 mM Tris-HCL, pH 8.1, 1 mM PMSF,
1 mg/ml leupeptin, 1 mg/ml aprotonin), followed by sonication
and centrifugation. The supernatant was precleared with sheared
salmon sperm DNA and protein G-Sepharose beads (Sigma).
The supernatant was incubated with specific antibodies over-
night, and then with protein G-Sepharose beads for 1 h. After an
extensive wash step, the complexes were eluted with buffer
(100 mmol/liter NaHCO3, 1% SDS) and incubated with pro-
teinase K. DNA was purified using QIAquick polymerase chain
reaction purification kit (Qiagen). PCR was performed using the
following primers:
JMJD2A: For, GGT CTC AAA CTG CCG ACT TC and
Rev, CCC TGA GGG TCA TTA GGA CA;
JMJD2B: For, GGC AGT GAT TGG CAC CTG and Rev,
GCC TCG CCT CTT CT TGG;
JMJD2C: For, GGG CAC CTT TAA GCT GTT TG and
Rev, TGG GAA ATT TGG GAG ACT TG;
CA9: For, GAC AAA CCT GTG AGA CTT TGG CTC C;
and Rev, AGT GAC AGC AGC AGT TGC ACA GTG.
Antibodies
Antibodies used were:
HIF-1a (610958, BD Biosciences and sc-53546 Santa Cruz),
HIF-2a (PA1–16510, Thermo Scientific), HIF-1b (3718, Cell
Signaling; AT1199a, Abgent; sc-5580, Santa Cruz), b-actin
(3700, Cell Signaling), p62/STQM (610832, BD Biosciences),
PARP (9532, Cell Signaling), Cleaved PARP (9541, Cell Signal-
ing), LC3B (3868, Cell Signaling), JMJD2A (3393, Cell Signal-
ing), JMJD2B (8639, Cell Signaling), JMJD2C (PA5-23065,
Thermo Scientific), H3K9me3 (9754, Cell Signaling), JMJD1B
(5377, Cell Signaling), PITX1 (A300-577A, Bethyl Labs), CA9
(NB100-417; Novus Biologicals).
Immunofluorescence, image analysis and quantification
For immunofluorescence, cells were grown on coverslips and
treated as indicated prior to fixation by incubation in 3.7% form-
aldehyde/PBS (pH 6.8) for 15 minutes. Cells were permeabilized
in PBS-0.1% Triton X-100 for 15 minutes and then blocked in
PBS-0.05% Tween-20 supplemented with 1% normal donkey
serum for 30 minutes. Primary antibodies were used at the fol-
lowing dilutions: PITX1 (Bethyl labs) 1:50; HIF-1b (Abgent)
1:100; HIF-1a (Santa Cruz) 1:50, HIF-1b (Santa Cruz) 1:100.
Cells were analyzed and images were acquired using a DeltaVi-
sion microscope. Images were deconvolved and analyzed using
OMERO client software (Open Microscopy Environment).38
For colocalisation analysis, Fiji software was used and colocalisa-
tion levels were measured using Spearman’s correlation coeffi-
cient value, where 1 signifies complete colocalisation and -1
signifies exclusion.
FRET analysis by acceptor photobleaching
Hela cells were co-transfected with mCh-PITX1 and GFP-
HIF-1b or respective empty vectors for 48 hours prior to fixation
Figure 6 (See previous page). deviation from a minimum of 3 independent experiments. (D) HeLa cells were transfected with control or PITX1 siRNA, or
empty vector or 1 mg PITX1 expression construct, prior to treatment with 1% O2 for 24 hours. Levels of proliferation were measured using Alamar blue,
48 hours post-transfection. (E) Hela cells were treated and in B, prior to cell cycle analysis by flow cytometry. Only S-phase data is presented in the graph
that represents the mean and standard deviation from a minimum of 3 independent experiments. (F) HeLa cells were treated as in D, but processed for
colony formation assay. Cells were stained and fixed 5 d post-transfection and colonies counted using ImageJ software. Graph depicts mean and stan-
dard deviation of a minimum of 3 independent experiments. Student’s t-test was performed to calculate p values, and levels of significance are denoted
as follows: *P < 0.05, **P < 0.01, and ***P < 0.001.
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with 3.7% formaldehyde. Cells were imaged in a Zeiss LSM 700
confocal microscope using a £100Plan Apochromat objective
(NA 1.46) and an optical section thickness of 0.7 um. The lasers
(488 and 555) and detectors were set to image GFP and
mCherry. Images of the same cells were acquired before and after
mCherry-PITX1 photobleaching (100 scans of the ROI at maxi-
mum laser (555) power) using identical scan conditions.
Acquired images were imported into OMERO. Donor intensities
were measured using the ROI tool in OMERO. Fret efficiency
was calculated by the following formula: E D (IDpost-IDpre)/
IDpost, where ID is donor intensity pre and post bleaching.
Cell cycle and apoptosis analysis
Cells were transfected with siRNA oligonucleotides for
48 hours prior to fixation in 70% ethanol. Fixed cells were kept
at ¡20C for a minimum of 30 minutes. Cells were then washed
in PBS, and stained with Guava Cell Cycle analysis solution
from Millipore (4500–02200), and cells were analyzed in a
Guava bench top flow cytometer.
Apoptosis analysis was performed on live cells, transfected
with siRNA oligonucleotides for 48 hours prior to staining. Cells
were resuspended in fresh completed growth media following
trypsination, and then stained with the Guava Nexin reagent
(4500–0450; Millipore) for detection of apoptosis by flow
cytometry. Cells were analyzed in a in a Guava bench top flow
cytometer.
Additional experimental procedures
Cell lysates were obtained as described in 39 and using RIPA
buffer. Western blot, colony formation assays, luciferase assays
were previously described in.39
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